tiprankstipranks
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Arcutis Biotherapeutics
$13.93
$1.62B
126.40%
5 Buy
0 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$63.25
$11.76B
37.17
-30.86%
12 Buy
3 Hold
0 Sell
Strong Buy
Xoma
$26.48
$314.60M
28.95%
2 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$2.36
$268.62M
106.03%
6 Buy
1 Hold
0 Sell
Strong Buy
Kura Oncology
$7.69
$620.55M
-63.12%
12 Buy
2 Hold
0 Sell
Strong Buy
Journey Medical Corp
$4.06
$86.90M
-20.39%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
ARQT
Arcutis Biotherapeutics
13.72
7.85
133.73%
BMRN
BioMarin Pharmaceutical
63.46
-26.16
-29.19%
XOMA
Xoma
26.50
5.95
28.95%
ACRS
Aclaris Therapeutics
2.39
1.18
97.52%
KURA
Kura Oncology
7.69
-13.16
-63.12%
DERM
Journey Medical Corp
4.06
-0.80
-16.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis